The Rho-kinase Inhibitor Y27632 Promotes Ureteral Relaxation in an in Vivo Rat Model for Partial Ureteral Obstruction

Overview

Journal World J Urol

Specialty Urology

Date 2023 Aug 1

PMID 37528287

Authors

Luca Villa

Philipp Weinhold

Emanuele Zaffuto

Fabio Castiglione

Edoardo Pozzi

Eugenio Ventimiglia

Roberta Buono

Alberto Briganti

Francesco Montorsi

Andrea Salonia

Petter Hedlund

Affiliations

Soon will be listed here.

Abstract

Purpose: Aim of this study was to evaluate the effect of intravenous Y27632 (a ROK inhibitor) on intra-ureteral pressures and on blood pressure in an in vivo rat model for unilateral partial ureteral obstruction (PUO).

Methods: 15 Male Sprague Dawley rats were used. Under isofluran anesthesia, saline was continuously infused via polyethylene (PE)-10 catheters inserted in the ureters beneath the kidney pelvis. Left psoas muscle was sutured around the distal left ureter to create a partial obstruction. Carotid artery and femoral vein were cannulated with PE catheters for registration of mean arterial blood pressure (MAP) and for administration of drugs. Left and right ureter pressures and MAP were simultaneously recorded. Y27632 (0.03 and 0.1 mg/kg each n = 6-7) was given intravenously. T-test was used for comparisons.

Results: Spontaneous peristaltic pressure waves were recorded at baseline for both ureters. After the obstruction, Y27632 reduced maximum pressure (MaxP) by 10.5 ± 1.9% (0.03 mg/kg; p = 0.004) and 29.1 ± 4.8% (0.1 mg/kg; p < 0.001), minimum pressure (MinP) by 5.2 ± 2.3% (0.03 mg/kg; p = 0.02) and 12.2 ± 3.4% (0.1 mg/kg; p = 0.009), the area under the curve (AUC) by 7.8 ± 2.4% (0.03 mg/kg; p = 0.008) and 16.5 ± 3.7% (0.1 mg/kg;p = 0.007), the waves amplitude by 23.4 ± 11.3% (0.03 mg/kg; p = 0.098) and 38.7 ± 7.5% (0.1 mg/kg; p < 0.001), with no effect on contraction frequency. During simultaneous recordings from the normal ureter at the investigated doses, Y27632 reduced MaxP, MinP, AUC and waves amplitude by 1-7%. The MAP was reduced by 12.5 ± 5.3% (0.03 mg/kg; p = 0.07) and 15.8 ± 1.8% (0.1 mg/kg; p < 0.001).

Conclusions: Y27632 decreased intra-ureteral pressures of a partially obstructed ureter with limited effect on blood pressure in an animal model of unilateral PUO.

References

Khan S, Pearle M, Robertson W, Gambaro G, Canales B, Doizi S . Kidney stones. Nat Rev Dis Primers. 2016; 2:16008. PMC: 5685519. DOI: 10.1038/nrdp.2016.8. View

Scales Jr C, Smith A, Hanley J, Saigal C . Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-5. PMC: 3362665. DOI: 10.1016/j.eururo.2012.03.052. View

Miller O, Kane C . Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999; 162(3 Pt 1):688-90; discussion 690-1. DOI: 10.1097/00005392-199909010-00014. View

Hollingsworth J, Canales B, Rogers M, Sukumar S, Yan P, Kuntz G . Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ. 2016; 355:i6112. PMC: 5131734. DOI: 10.1136/bmj.i6112. View

Assimos D, Krambeck A, Miller N, Monga M, Murad M, Nelson C . Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II. J Urol. 2016; 196(4):1161-9. DOI: 10.1016/j.juro.2016.05.091. View

Ye Z, Zeng G, Yang H, Tang K, Zhang X, Li H . Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Eur Urol. 2017; 73(3):385-391. DOI: 10.1016/j.eururo.2017.10.033. View

Lee C, Cheah J, Soule C, Ding H, Whittaker C, Karhohs K . Identification and local delivery of vasodilators for the reduction of ureteral contractions. Nat Biomed Eng. 2019; 4(1):28-39. PMC: 7962136. DOI: 10.1038/s41551-019-0482-4. View

Turna B, Cinar M, Canda A, Orhan E, Tiftik N, Nazli O . Role of Rho-kinase in contractions of ureters from rabbits with unilateral ureteric obstruction. BJU Int. 2007; 100(5):1166-71. DOI: 10.1111/j.1464-410X.2007.07152.x. View

Lim I, Chess-Williams R, Sellers D . Altered ureteral contractility with ageing: Role of the rho-kinase pathway. Mech Ageing Dev. 2018; 171:31-36. DOI: 10.1016/j.mad.2018.03.004. View

10.

Kilkenny C, Browne W, Cuthill I, Emerson M, Altman D . Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010; 8(6):e1000412. PMC: 2893951. DOI: 10.1371/journal.pbio.1000412. View

11.

Villa L, Buono R, Fossati N, Rigatti P, Montorsi F, Benigni F . Effects by silodosin on the partially obstructed rat ureter in vivo and on human and rat isolated ureters. Br J Pharmacol. 2013; 169(1):230-8. PMC: 3632251. DOI: 10.1111/bph.12123. View

12.

Hou W, Wen J, Ji Z, Chen J, Li H . Reflex anuria: an old concept with new evidence. Int Urol Nephrol. 2013; 46(2):323-8. DOI: 10.1007/s11255-013-0541-9. View

13.

Panda S, Bajpai M, Sinha A, Mallick S, Sharma M . Effect of ipsilateral ureteric obstruction on contralateral kidney and role of renin angiotensin system blockade on renal recovery in experimentally induced unilateral ureteric obstruction. J Indian Assoc Pediatr Surg. 2013; 18(2):58-61. PMC: 3687147. DOI: 10.4103/0971-9261.109353. View

14.

Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T . Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997; 389(6654):990-4. DOI: 10.1038/40187. View

15.

Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H . Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol. 2002; 40(5):751-61. DOI: 10.1097/00005344-200211000-00013. View

16.

Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium D . Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res. 2004; 61(3):548-58. DOI: 10.1016/j.cardiores.2003.12.004. View

17.

Ikeda F, Terajima H, Shimahara Y, Kondo T, Yamaoka Y . Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632. J Surg Res. 2003; 109(2):155-60. DOI: 10.1016/s0022-4804(02)00081-1. View

18.

Teraishi K, Kurata H, Nakajima A, Takaoka M, Matsumura Y . Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats. Eur J Pharmacol. 2004; 505(1-3):205-11. DOI: 10.1016/j.ejphar.2004.10.040. View

19.

Hong S, Kwak C, Jeong B, Kim B, Kim H . Involvement of Rho-kinase in the contractile mechanism of human ureteral smooth muscle. Neurourol Urodyn. 2005; 24(2):136-41. DOI: 10.1002/nau.20096. View

20.

Shabir S, Borisova L, Wray S, Burdyga T . Rho-kinase inhibition and electromechanical coupling in rat and guinea-pig ureter smooth muscle: Ca2+-dependent and -independent mechanisms. J Physiol. 2004; 560(Pt 3):839-55. PMC: 1665275. DOI: 10.1113/jphysiol.2004.070615. View